Karade Santosh, Patil Ajit A, Ghate Manisha, Kulkarni Smita S, Kurle Swarali N, Risbud Arun R, Rewari Bharat B, Gangakhedkar Raman R
1 HIV Drug Resistance Laboratory, National AIDS Research Institute , Pune, India .
2 Maharashtra University of Health Sciences , Nashik, India .
AIDS Res Hum Retroviruses. 2016 Apr;32(4):377-80. doi: 10.1089/AID.2015.0277. Epub 2016 Jan 7.
In India, the roll out of the free antiretroviral therapy (ART) program completed a decade of its initiation in 2014. The success of first-line ART is influenced by prevalence of HIV pretreatment drug resistance (PDR) in the population. In this cross-sectional study, we sought to determine the prevalence of PDR among adults attending the state-sponsored free ART clinic in Pune in western India. Fifty-two individuals eligible for ART as per national guidelines with median CD4 cell count of 253 cells/mm(3) (inter quartile range: 149-326) were recruited between January 2014 and April 2015. Population-based sequencing of partial pol gene sequences from plasma specimen revealed predominant HIV-1 subtype C infection (96.15%) and presence of single-drug resistance mutations against non-nucleoside reverse transcriptase inhibitor in two sequences. The study supports the need for periodic surveillance, when offering PDR testing at individual level is not feasible.
在印度,免费抗逆转录病毒疗法(ART)项目自2004年启动以来已历经十年。一线抗逆转录病毒疗法的成效受到人群中HIV治疗前耐药性(PDR)流行情况的影响。在这项横断面研究中,我们试图确定印度西部浦那市参加政府资助的免费抗逆转录病毒疗法诊所的成年人中PDR的流行情况。2014年1月至2015年4月期间,招募了52名符合国家指南中抗逆转录病毒疗法标准的个体,其CD4细胞计数中位数为253个细胞/立方毫米(四分位间距:149 - 326)。对血浆样本中部分pol基因序列进行基于人群的测序,结果显示主要为HIV - 1 C亚型感染(96.15%),且有两个序列存在针对非核苷类逆转录酶抑制剂的单药耐药突变。该研究支持了在无法在个体层面进行PDR检测时开展定期监测的必要性。